SCHEMBL7803295

SCHEMBL7803295

Nc1ncnc2c1ncn2[C@@H]1O[C@H](C(O)O)[C@@H](O)[C@H]1O

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AHCY P23526 11/20 0.67
▸ PRMT5 O14744 1/20 0.67
▸ WDR77 Q9BQA1 1/20 0.67
▸ ADORA2A P29274 2/20 0.66
▸ ADORA2B P29275 2/20 0.66
▸ ADORA3 P0DMS8 2/20 0.66
▸ DPP4 P27487 1/20 0.66
▸ MEN1 O00255 1/20 0.66
▸ SLC28A1 O00337 1/20 0.66
▸ MAP3K7 O43318 1/20 0.66
▸ SLC28A2 O43868 1/20 0.66
▸ GAPDH P04406 1/20 0.66
▸ MAPK1 P28482 1/20 0.66
▸ ADORA1 P30542 1/20 0.66
▸ STAT6 P42226 1/20 0.66
▸ PI4KA P42356 1/20 0.66
▸ KMT2A Q03164 1/20 0.66
▸ SMN1; SMN2 Q16637 1/20 0.66
▸ PI4K2B Q8TCG2 1/20 0.66
▸ DOT1L Q8TEK3 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6671788 1.00 AHCY (0.67) AHCYPRMT5WDR77ADORA2AADORA2B
SCHEMBL31680251 0.94 AHCY (0.68) AHCYPRMT5WDR77ADORA2AADORA2B
SCHEMBL397800 0.94 AHCY (0.68) AHCYPRMT5WDR77ADORA2AADORA2B
SCHEMBL2040666 0.91 PRMT5 (0.66) AHCYPRMT5WDR77ADORA2AADORA2B
SCHEMBL10997934 0.90 AHCY (0.65) AHCYPRMT5WDR77ADORA2AADORA2B
SCHEMBL21413837 0.90 PRMT5 (0.64) AHCYPRMT5WDR77ADORA2AADORA2B
SCHEMBL16300875 0.90 PRMT5 (0.64) AHCYPRMT5WDR77ADORA2AADORA2B
SCHEMBL22326785 0.90 PRMT5 (0.64) AHCYPRMT5WDR77ADORA2AADORA2B
SCHEMBL22326787 0.90 PRMT5 (0.64) AHCYPRMT5WDR77ADORA2AADORA2B
SCHEMBL800346 0.90 PRMT5 (0.64) AHCYPRMT5WDR77ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6210917-B1 BY TREATING METHYLTHIOADENOSINE PHOSPHORYLASE DEFICIENT CELLS WITH ADENINE SYNTHESIS INHIBITOR TO DEPLETE THE TARGET CELLS OF ADENOSINE 5'-TRIPHOSPHATE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2001-04-03 — — US disclosed
EP-1034299-A4 METHOD FOR SUPPRESSING MULTIPLE DRUG RESISTANCE IN CANCER CELLS UNIV CALIFORNIA (US) 2001-03-07 — — EP disclosed
EP-1034299-A1 METHOD FOR SUPPRESSING MULTIPLE DRUG RESISTANCE IN CANCER CELLS The Regents of the University of California (US) 2000-09-13 — — EP disclosed
WO-1999020791-A1 METHOD FOR SUPPRESSING MULTIPLE DRUG RESISTANCE IN CANCER CELLS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1999-04-29 — — WO disclosed
Send feedback